Diagnostic Markers of Language Impairment in Spanish-English speakers

Study Description:
Our goal is to improve services for Spanish-English speaking adults who need to see a Speech-Language Pathologist due to brain injury. We are developing language assessments to more accurately diagnose conditions such as aphasia and dementia. We aim to improve access to speech-language therapy services for bilingual speakers and reduce health disparities with our research. For some background information, we are recruiting adult speakers who are 30-70 years old and are: monolingual English speakers, or highly proficient Spanish-English bilingual speakers, or Spanish-English bilingual speakers with a diagnosis of aphasia, who were highly proficient in both languages prior to their brain injury. All participation will be completed online over the computer. For monolingual English speakers, the procedures involve a 15-minute phone screen, and 2 hours of testing, and they will be reimbursed $50 at the completion of the study. For bilingual Spanish-English speakers, the procedures involve a 25 minute phone screen and 5 hours of testing (over two to three sessions). They will be reimbursed $100 at the completion of the study.
Aphasia Friendly Study Description:
We are developing aphasia tests for bilingual Spanish-English speakers. You are eligible if you are a Spanish-English speaker with aphasia. You will participate online over a computer. Participation invovles 25 minute phone screen and two to three sessions of testing (about 5 hours total). You will be paid $100 at the completion of the study.
Inclusion / Exclusion Criteria:
Bilingual people with aphasia, any age over 18, and neurotypical bilingual and monolingual people from ages 30-70.
Principal Investigator:
Yasmeen Faroqi-Shah
Contact Email:
yfshah@umd.edu
Condition
Stroke
Observational or Treatment:
Observational
Type of Treatment:
n/a
Duration of Study:
25 minute phone screen and two to three sessions of testing (about 5 hours total)
Study Start Date:
July 1, 2022
Study End Date:
June 30, 2023
More information:
Costs or Reimbursement:
$100 Reimbursement
IRB Approval #
1726372
Contact
Back to Listings